Alzheimer Diagnosis Possible With Scan.

The article discusses a test developed by drug company Eli Lilly & Co. and approved by the U.S. Food and Drug Administration that can detect amyloid proteins on the brain that are associated with Alzheimer's disease. The Lilly test involves administering the chemical florbetapir, which adheres to the proteins and can be detected via positron emission tomography.